UF Department of Radiation Oncology Praises Single-Use Scopes

Performing Procedures

University Touts Transition to Single-Use Rhinolaryngoscopes

"The COVID-19 pandemic has forced us all to take a look at how we balance careful infection control with fiscal and environmental responsibility."

The University of Florida recently transitioned to single-use rhinolaryngoscopes to diagnose and treat head and neck cancers.

The university’s radiation oncology department cited improved image quality and infection control among the reasons for the switch.

The UF Department of Radiation Oncology now uses the Ambu aScope 4 RhinoLaryngo for its patients, according to the university’s website.

“The COVID-19 pandemic has forced us all to take a look at how we balance careful infection control with fiscal and environmental responsibility,” Dr. Kathryn Hitchcock, a physician and assistant professor, said in the online statement.  “Once we saw the excellent clarity of the images provided by these devices, we knew they were the answer.”

The oncology department says the aScope RhinoLaryngo increases comfort and safety for patients during rhinolaryngoscopy. It's a small, flexible fiber-optic tube used to examine a patient’s airway and throat. Images and videos captured during procedures are then used by doctors to help with diagnosis and treatment planning.

Quality images can help identify head and neck cancers, and early detection of those cancers leads to improved survival rates and quality of life.

UF's announcement — released independent of Ambu — underscored its need for quality diagnostic equipment with statistics about the prevalence of head and neck cancers. Based on the most current data available from GLOBOCAN, new instances of head and neck cancers make the grouping the seventh most common cancer worldwide. Head and neck cancers include cancers of the oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands.

The Ambu scopes also help satisfy the university’s goals in terms of environmental responsibility with “a clear plan for keeping these materials out of landfills," university officials said.

Once used, the disposable devices are transported to specialized facilities where they are disassembled and converted to raw materials and energy.

Physicians at multiple academic hospitals across the U.S. scored the Ambu single-use rhinolaryngoscope superior in setup and convenience and better overall than reusable competitors. Those findings were detailed in a recent study published in Laryngoscope Investigative Otolaryngology.

The Ambu scope was found to be comparable to reusables in ergonomics and maneuverability and more cost effective, with no repairs or reprocessing needed for the same types of procedures.

More ENT Articles
Quantifying Infection Risk and Cost-Effectiveness in Bronchoscopy
Value-Based Care
The total cost per use of a single-use bronchoscope is 12 percent less than for a reusable bronchoscope, according to a new study. Single-use bronchoscopes also help significantly reduce infection risk, further decreasing potential costs per procedure.
Does Microbial Testing Make Financial Sense?
Value-Based Care
U.S. multisociety guidelines have no preferred recommendation for testing the adequate reprocessing of endoscopes. Microbial testing is timely and costly but, given the cost associated with transmitting an infection, is the time and money worth it?
More From Single-Use Endoscopy
A Doctor

Preventing Infection

At the recent Becker’s Hospital Review 11th Annual Meeting, Dr. James Horowitz shared his thoughts on the value of single-use bronchoscopes based, in part, on his experience on the front line of a busy New York City hospital early in the pandemic.

FDA Adds New Guidance for Reusable Bronchoscopes

Preventing Infection

The update to a safety communications first issued in 2015 calls for sterilization of reusable bronchoscopes and using single-use devices on immunocompromised patients.

What is the Role of Patient COVID Tests in Keeping Healthcare Workers Safe?

Preventing Infection

Research from the University of Florida examined the value of mandated COVID testing of asymptomatic patients before bronchoscopy procedures in reducing risk to healthcare workers. Find out what happened in one hospital that did not require such testing.